Brief: Cantargia Receives Regulatory Approval To Start Trifour Study In Triple Negative Breast Cancer

Cantargia AB

29/09/2021 15:31

Sept 29 (Reuters) - Cantargia AB  CANTA.ST :
    * CANTARGIA RECEIVES REGULATORY APPROVAL TO START TRIFOUR
STUDY IN
TRIPLE NEGATIVE BREAST CANCER
    * FIRST PATIENT IS EXPECTED TO BE ENROLLED IN NOVEMBER 2021
    * PRIMARY OBJECTIVE WILL BE TO EVALUATE SAFETY AND
TOLERABILITY
AND TO ESTABLISH A RECOMMENDED DOSE FOR SUBSEQUENT PART
    * BIOMARKERS AND EARLY SIGNS OF EFFICACY WILL ALSO BE
EVALUATED

Source text for Eikon:  ID:nWkr8CVtsJ 
Further company coverage:  CANTA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))